Ensign Peak Advisors, Inc Insmed Inc Transaction History

Ensign Peak Advisors, Inc

$51.2 Billion
Q1 2025

A detailed history of Ensign Peak Advisors, Inc transactions in Insmed Inc stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 589,399 shares of INSM stock, worth $59.3 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

589,399

Previous 529,049 11.41%

Holding current value

$59.3 Million

Previous $36.5 Million 23.11%

% of portfolio

0.09%

Previous 0.07%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$65.25 - $83.83 $3.94 Million - $5.06 Million	60,350 Added 11.41%	589,399 $45 Million
Q4 2024 Feb 13, 2025	BUY	$66.29 - $76.63 $2.98 Million - $3.44 Million	44,928 Added 9.28%	529,049 $36.5 Million
Q3 2024 Nov 14, 2024	BUY	$62.0 - $79.01 $7.76 Million - $9.88 Million	125,092 Added 34.84%	484,121 $35.3 Million
Q2 2024 Aug 13, 2024	BUY	$22.0 - $69.71 $384,010 - $1.22 Million	17,455 Added 5.11%	359,029 $24.1 Million
Q1 2024 May 14, 2024	BUY	$25.72 - $29.94 $6.98 Million - $8.13 Million	271,564 Added 387.89%	341,574 $9.27 Million
Q4 2023 Feb 14, 2024	BUY	$23.42 - $31.74 $101,642 - $137,751	4,340 Added 6.61%	70,010 $2.17 Million
Q1 2023 May 15, 2023	SELL	$16.26 - $21.73 $3.8 Million - $5.08 Million	-233,553 Reduced 78.05%	65,670 $1.12 Million
Q4 2022 Feb 13, 2023	BUY	$16.98 - $23.15 $1.5 Million - $2.04 Million	88,100 Added 41.73%	299,223 $5.98 Million
Q3 2022 Nov 14, 2022	BUY	$20.88 - $28.21 $1.03 Million - $1.39 Million	49,426 Added 30.57%	211,123 $4.55 Million
Q2 2022 Aug 12, 2022	BUY	$17.07 - $25.71 $2 Million - $3.01 Million	116,937 Added 261.25%	161,697 $3.19 Million
Q1 2022 May 16, 2022	BUY	$20.42 - $28.13 $338,972 - $466,958	16,600 Added 58.95%	44,760 $1.05 Million
Q4 2021 Feb 11, 2022	BUY	$25.89 - $33.45 $729,062 - $941,952	28,160 New	28,160 $767,000

Others Institutions Holding INSM

# of Institutions

489

Shares Held

197M

Call Options Held

892K

Put Options Held

1.77M

View Full List

About INSMED Inc

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $13.6B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

More about INSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.

Account

Ensign Peak Advisors, Inc Insmed Inc Transaction History